sg 209 has been researched along with phenylephrine in 1 studies
| Studies (sg 209) | Trials (sg 209) | Recent Studies (post-2010) (sg 209) | Studies (phenylephrine) | Trials (phenylephrine) | Recent Studies (post-2010) (phenylephrine) |
|---|---|---|---|---|---|
| 15 | 0 | 3 | 13,797 | 857 | 2,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamaguchi, M; Imai, S; Ishibashi, T | 1 |
1 other study(ies) available for sg 209 and phenylephrine
| Article | Year |
|---|---|
2-Nicotinamidoethyl acetate (SG-209) is a potassium channel opener: structure activity relationship among nicorandil derivatives.
Topics: Animals; Cyclic GMP; Glyburide; Male; Methylene Blue; Niacinamide; Nicorandil; Phenylephrine; Potassium Channels; Rabbits; Structure-Activity Relationship; Vasodilation; Vasodilator Agents | 1991 |